{"product_id":"carotid-artery-ultrasound-and-heart-risk-is-this-simple-painless-test-still-worthwhile","title":"Carotid Artery Ultrasound and Heart Risk: Is This Simple, Painless Test Still Worthwhile?","description":"\u003cp\u003eCarotid artery ultrasound is a safe, painless imaging test that lets doctors see the walls of the carotid arteries—the main blood vessels in the neck that supply blood to the brain—to check for early signs of atherosclerosis (hardening and narrowing of the arteries). This review article examines whether measuring carotid intima-media thickness (IMT), a key ultrasound measurement, is still valuable for predicting heart attacks and strokes, especially after 2013 guidelines discouraged its routine use. The authors conclude that while measuring the common carotid artery IMT alone has limitations, combining IMT with plaque detection—including plaque size, burden, and tissue characteristics—using modern 3D ultrasound offers significantly better risk prediction. Blood flow measurements also show promise, but more research is needed before they can be widely used in everyday clinical practice.\u003c\/p\u003e\n\n\u003ch1\u003eCarotid Artery Ultrasound and Heart Risk: Is This Simple, Painless Test Still Worthwhile?\u003c\/h1\u003e\n\n\u003ch2\u003eTable of Contents\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#ddn-key-points\"\u003eKey Points\u003c\/a\u003e\u003c\/li\u003e\n\n  \u003cli\u003e\u003ca href=\"#background\"\u003eWhy This Research Matters\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#understanding\"\u003eUnderstanding Carotid Ultrasound and Intima-Media Thickness (IMT)\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#guideline\"\u003eThe 2013 Guidelines That Changed Clinical Practice\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#methods\"\u003eHow This Review Was Conducted\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#location\"\u003eKey Finding: Which Part of the Carotid Artery Is Best to Measure?\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#imt-vs-plaque\"\u003eKey Finding: IMT vs. Plaque—Which Predicts Heart Risk Better?\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#plaque\"\u003eUnderstanding Carotid Plaque: Types, Tissue, and Burden\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#biomarkers\"\u003eCombining Ultrasound with Other Heart Risk Biomarkers\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#bloodflow\"\u003eMeasuring Blood Flow in the Carotid Artery\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#implications\"\u003eWhat This Means for Patients\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#limitations\"\u003eLimitations: What This Review Could Not Prove\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#recommendations\"\u003eRecommendations and Future Directions\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#ddn-faq\"\u003eFrequently Asked Questions\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#source\"\u003eSource Information\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003c!-- ddn:keypoints:start --\u003e\n\u003ch2 id=\"ddn-key-points\"\u003eKey Points\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003eCarotid ultrasound is safe, painless, and can detect early atherosclerosis, but measuring IMT alone is no longer routinely recommended.\u003c\/li\u003e\n\u003cli\u003eCarotid plaque is a stronger predictor of cardiovascular risk than IMT alone; checking for plaque presence and characteristics adds value.\u003c\/li\u003e\n\u003cli\u003eThe common carotid artery is easiest to measure reliably, but bulb and internal carotid measurements predict risk better, though harder to obtain.\u003c\/li\u003e\n\u003cli\u003eBlood flow velocity, especially end-diastolic velocity, is associated with future events and may improve risk prediction, but needs more research.\u003c\/li\u003e\n\u003cli\u003eCombining carotid ultrasound with other biomarkers like hs-CRP or coronary calcium score gives a more complete risk assessment.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c!-- ddn:keypoints:end --\u003e\n\n\n\u003ch2 id=\"background\"\u003eWhy This Research Matters\u003c\/h2\u003e\n\u003cp\u003eHeart disease and stroke remain leading causes of death worldwide. Detecting atherosclerosis early—before it causes a heart attack or stroke—is one of the most important goals of preventive medicine. Doctors have several tools to assess cardiovascular risk, including blood pressure measurements, cholesterol tests, and risk calculators. But these tools don't always tell the whole story.\u003c\/p\u003e\n\u003cp\u003eCarotid ultrasound offers something different: a direct, real-time look at the actual artery wall. It's non-invasive (no needles or surgery), painless, relatively inexpensive, and involves no radiation. That makes it an attractive option for screening. But is it actually useful enough to change treatment decisions? That question became highly controversial in 2013, when major American guidelines suddenly downgraded one of its key measurements. This review article, written by Korean cardiologists Dr. Gee-Hee Kim and Dr. Ho-Joong Youn, takes a detailed look at the evidence both for and against the continued use of carotid ultrasound.\u003c\/p\u003e\n\n\u003ch2 id=\"understanding\"\u003eUnderstanding Carotid Ultrasound and Intima-Media Thickness (IMT)\u003c\/h2\u003e\n\u003cp\u003eYour carotid arteries have four segments: the common carotid artery (CCA), the bifurcation (also called the bulb, where the artery splits), the external carotid artery, and the internal carotid artery (ICA), which carries blood to the brain. When doctors perform a carotid ultrasound, they can measure several things, including the thickness of the artery wall, the presence of plaque, blood flow velocity, and arterial diameter.\u003c\/p\u003e\n\u003cp\u003eThe key measurement is called \u003cstrong\u003eintima-media thickness (IMT)\u003c\/strong\u003e. The artery wall has three layers: the intima (innermost layer), the media (middle muscular layer), and the adventitia (outer layer). On a B-mode ultrasound image, the arterial wall appears as a \u003cstrong\u003e\"double-line pattern\"\u003c\/strong\u003e—the inner line represents the intima surface, and the outer line represents the media. Carotid IMT is defined as the distance between the luminal border of the intima and the outer border of the media on the far wall of the artery.\u003c\/p\u003e\n\u003cp\u003eThink of it like measuring the thickness of a pipe wall. Just as a pipe wall thickens with rust and buildup, the artery wall thickens as atherosclerosis develops. The beauty of ultrasound is that it can measure this thickening non-invasively, using sound waves that bounce off the tissue to create an image.\u003c\/p\u003e\n\u003cp\u003eMultiple large studies have shown that carotid IMT and the presence of plaque predict future cardiovascular events (heart attacks, strokes, and related deaths). Even in people considered low-risk, screening with IMT and plaque assessment can detect subclinical atherosclerosis—meaning the disease is present but hasn't caused symptoms yet.\u003c\/p\u003e\n\n\u003ch2 id=\"guideline\"\u003eThe 2013 Guidelines That Changed Clinical Practice\u003c\/h2\u003e\n\u003cp\u003eIn 2013, the \u003cstrong\u003eAmerican College of Cardiology\/American Heart Association (ACC\/AHA)\u003c\/strong\u003e released new guidelines for cardiovascular risk assessment. These guidelines designated carotid IMT as \u003cstrong\u003eClass III evidence\u003c\/strong\u003e, meaning it was \u003cstrong\u003enot recommended\u003c\/strong\u003e for routine use in clinical practice as a measurement of risk for a first atherosclerotic cardiovascular disease (ASCVD) event. This was a major shift—overnight, a widely used measurement was effectively de-prioritized.\u003c\/p\u003e\n\u003cp\u003eThe announcement sparked considerable debate among cardiologists and ultrasound specialists. Dr. Naqvi and colleagues later argued that the controversy over carotid IMT's usefulness stems largely from the \u003cstrong\u003elack of a uniform methodology\u003c\/strong\u003e across studies. Different research groups measured IMT in different artery segments, used different definitions of plaque, and applied different statistical models—making it hard to compare results and draw consistent conclusions.\u003c\/p\u003e\n\u003cp\u003eThis review article was written to evaluate what researchers have learned since that 2013 guideline was announced, and to assess whether carotid ultrasound still deserves a place in clinical practice.\u003c\/p\u003e\n\n\u003ch2 id=\"methods\"\u003eHow This Review Was Conducted\u003c\/h2\u003e\n\u003cp\u003eThis is a \u003cstrong\u003ereview article\u003c\/strong\u003e, not a new clinical trial. The authors—Dr. Gee-Hee Kim from St. Vincent's Hospital in Suwon and Dr. Ho-Joong Youn from Seoul St. Mary's Hospital, both affiliated with The Catholic University of Korea—systematically examined studies published after the 2013 ACC\/AHA guideline announcement. Their goal was to evaluate the evidence on carotid IMT for ASCVD risk prediction and estimation in specific conditions.\u003c\/p\u003e\n\u003cp\u003eThe review covers several categories of research:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eStudies comparing IMT measurements at different carotid artery segments (CCA, bulb, and ICA)\u003c\/li\u003e\n  \u003cli\u003eStudies comparing IMT vs. plaque as predictors of cardiovascular events\u003c\/li\u003e\n  \u003cli\u003eStudies using separate measurements of the intima and media layers\u003c\/li\u003e\n  \u003cli\u003eStudies using hemodynamic (blood flow) parameters such as peak-systolic velocity (PSV), end-diastolic velocity (EDV), and resistive index (RI)\u003c\/li\u003e\n  \u003cli\u003eStudies combining carotid ultrasound with other biomarkers like high-sensitivity C-reactive protein (hs-CRP), coronary artery calcium score (CACS), and ankle-brachial index (ABI)\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"location\"\u003eKey Finding: Which Part of the Carotid Artery Is Best to Measure?\u003c\/h2\u003e\n\u003cp\u003eOne of the most important practical questions is which segment of the carotid artery to measure. Not all segments are equally easy to image or equally informative. The data reveal a clear trade-off between reliability and predictive power.\u003c\/p\u003e\n\u003cp\u003eRegarding image quality and reliability, two large studies provide striking numbers:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eIn the \u003cstrong\u003eAtherosclerosis Risk in Communities (ARIC) study\u003c\/strong\u003e, 91.4% of CCA-IMT segments could be adequately imaged, compared with only 77.3% of bulb IMT segments and just 48.6% of ICA-IMT segments.\u003c\/li\u003e\n  \u003cli\u003eIn the \u003cstrong\u003eRotterdam study\u003c\/strong\u003e, carotid IMT measurements were possible in 96% of CCA-IMT segments, compared with 64% of bulb-IMT segments and only 31% of ICA-IMT segments.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eClearly, the common carotid artery is the easiest and most reliable segment to measure. The ICA is difficult to image adequately, which limits its usefulness in routine practice. For accuracy and best reproducibility, the CCA far wall IMT measurement has been validated as representing the true thickness of the vessel wall. The development of automated edge-detection programs (software that automatically identifies the artery wall boundaries) has increased measurement speed and reduced variability compared with older manual techniques.\u003c\/p\u003e\n\u003cp\u003eHowever, there's a catch. When it comes to predicting risk, the less reliable segments may actually be more informative. Studies found that including the carotid bulb and ICA-IMT measurements made them \u003cstrong\u003ebetter predictors of both cardiac risk and stroke risk\u003c\/strong\u003e than CCA-IMT alone. This creates a clinical dilemma: the easiest measurement to obtain (CCA-IMT) is the least predictive, while the more predictive measurements (bulb and ICA) are harder to obtain reliably.\u003c\/p\u003e\n\n\u003ch3\u003eSeparate Measurements of Intima and Media: A More Detailed Look\u003c\/h3\u003e\n\u003cp\u003eCarotid IMT is actually the sum of two separate layers: the \u003cstrong\u003eintima thickness (IT)\u003c\/strong\u003e and the \u003cstrong\u003emedia thickness (MT)\u003c\/strong\u003e. Instead of measuring them together, some researchers have explored measuring each layer separately. This matters because the two layers respond differently to different risk factors.\u003c\/p\u003e\n\u003cp\u003eAn animal study using a 40 MHz ultrasound probe found that the carotid high-echogenic intimal thickening (HEIT) correlates closely with the histological (microscopic) intima thickness. This means ultrasound can accurately measure the intima layer when high-frequency probes are used.\u003c\/p\u003e\n\u003cp\u003eThe research shows that:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eEarly atherosclerosis\u003c\/strong\u003e primarily affects the intima layer (IT)\u003c\/li\u003e\n  \u003cli\u003eThus, IT can be a useful parameter for \u003cstrong\u003eearly detection\u003c\/strong\u003e, predicting progression, and evaluating atherosclerosis\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHigh blood pressure (hypertension)\u003c\/strong\u003e increases the media layer (MT), consistent with medial hypertrophy (thickening of the muscular layer)\u003c\/li\u003e\n  \u003cli\u003eSeparate measurement of IT and MT is useful for evaluating how different atherosclerotic risk factors affect different parts of the arterial wall\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eHowever, there are major technical limitations. The theoretical axial resolution of a standard 7 MHz ultrasound transducer is approximately 0.3 mm. High-frequency transducers (about 11–15 MHz) can achieve a pixel resolution of approximately 0.1 to 0.2 mm. The problem? The mean intima thickness is approximately \u003cstrong\u003e0.2 mm\u003c\/strong\u003e—which means it can be intermittently or inadequately measured even with high-frequency transducers. If the IMT complex is thinner than 0.3 mm, the leading edges of the two echo interfaces (from the far wall intima and adventitia) cannot be separated, and measurement of the intima-media complex is not possible using a standard 7 MHz transducer.\u003c\/p\u003e\n\u003cp\u003eAnother critical limitation: the annual change of carotid IMT in the general population is approximately \u003cstrong\u003e0.01 to 0.04 mm per year\u003c\/strong\u003e (and similar in patients with disease). This rate of change is lower than the current resolution of ultrasound. In plain terms, the yearly thickening of the artery wall is smaller than the smallest measurement the machine can reliably detect. Therefore, it is essentially impossible to analyze carotid IMT changes over a short period—like monitoring a patient for a year or two to see if treatment is working.\u003c\/p\u003e\n\u003cp\u003eThe authors note that a more detailed and elaborate technique needs to be developed. If separate measurement of IT and MT can be perfected, it could play an important role in assessing atherosclerosis and arterial wall changes according to various risk factors, such as metabolic syndrome.\u003c\/p\u003e\n\n\u003ch2 id=\"imt-vs-plaque\"\u003eKey Finding: IMT vs. Plaque—Which Predicts Heart Risk Better?\u003c\/h2\u003e\n\u003cp\u003eA meta-analysis of 14 population-based studies evaluated carotid IMT and plaque for cardiovascular risk prediction. The findings were nuanced. When CCA-IMT alone was added to the Framingham Risk Score (a widely used risk calculator), it was associated with only a small improvement in 10-year risk prediction of first-time heart attack or stroke—an improvement the researchers said is \u003cstrong\u003e\"unlikely to be of clinical importance.\"\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHowever, when the carotid bulb and ICA-IMT were included, the measurements became better predictors of both cardiac risk and stroke risk. And critically, \u003cstrong\u003ecarotid plaque appears to be a more powerful predictor of cardiovascular risk than carotid IMT alone.\u003c\/strong\u003e This is one of the most important takeaways from this review: if you have to choose between measuring IMT or looking for plaque, plaque wins.\u003c\/p\u003e\n\u003cp\u003eThe authors emphasize that many previous studies showed discrepant results because they differed widely in methodology:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eWhich segments were evaluated (CCA, ICA, or the carotid bulb)\u003c\/li\u003e\n  \u003cli\u003eThe type of measurements used (mean or maximum of single measurements, mean of the mean, or mean of the maximum for multiple measurements)\u003c\/li\u003e\n  \u003cli\u003eWhether plaques were included in the IMT measurement\u003c\/li\u003e\n  \u003cli\u003eWhether statistical models were adjusted or unadjusted\u003c\/li\u003e\n  \u003cli\u003eWhether the study looked at risk association vs. risk prediction\u003c\/li\u003e\n  \u003cli\u003eThe arbitrary cutoff points used for IMT and plaque\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eAfter the 2013 ACC\/AHA guideline, the ARIC study reported that coronary heart disease (CHD) risk prediction can be improved by adding all carotid artery segments (A-CIMT) including the presence of plaque, or CCA-IMT plus plaque information, to traditional risk factors—compared with CCA-IMT alone. Since measuring CCA-IMT is easier and more reliable than measuring all segments, the researchers concluded that \u003cstrong\u003eevaluating the carotid artery for plaque presence and measuring CCA-IMT together provide a good parameter for CHD risk prediction.\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003ch3\u003eWhat the Studies Show in Specific Patient Groups\u003c\/h3\u003e\n\u003cp\u003eThe review highlights how the value of carotid ultrasound varies depending on the patient population:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAsymptomatic high-risk patients:\u003c\/strong\u003e A recent study found carotid plaque was more useful as an additive predictive factor for primary prevention of ASCVD than CCA-IMT alone.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHeart attack survivors:\u003c\/strong\u003e CCA-IMT and carotid plaque were both useful prognostic parameters for predicting long-term future cardiovascular events in patients with well-treated ST-elevation myocardial infarction (STEMI). The value of CCA-IMT in predicting events appeared to be clinically important beyond traditional risk factors in this relatively low-risk post-heart-attack population.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePatients with one or more traditional risk factors:\u003c\/strong\u003e Carotid plaque was more useful as an additive predictive factor for both primary and secondary prevention of ASCVD than CCA-IMT alone.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eYounger patients with hypertension:\u003c\/strong\u003e In a small study, no significant differences in clinical outcomes from cardiovascular events (including death, heart attack, and stroke) were observed between the highest and lowest CCA-IMT values (based on inter-quartile range) in younger subjects (males under 45 years and females under 55 years).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eYoung Iranian population:\u003c\/strong\u003e Another study found that, within a relatively young population without a history of cardiovascular events, thicker carotid IMT did not associate with several modifiable cardiovascular risk factors.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eElderly hypertensive patients (60+):\u003c\/strong\u003e Interestingly, only calcified carotid plaques (except for mean A-CIMT) predicted mortality and cardiovascular outcomes above other traditional risk factors such as age, sex, and hypertensive status.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThese findings suggest that the usefulness of carotid IMT measurement is not uniform across all patients—it depends heavily on age, risk profile, and what other risk factors are present.\u003c\/p\u003e\n\n\u003ch2 id=\"plaque\"\u003eUnderstanding Carotid Plaque: Types, Tissue, and Burden\u003c\/h2\u003e\n\u003cp\u003eCarotid plaque is identified on ultrasound as an echoic (bright) focal projection, or as focal wall thickening that is at least 50% greater than that of the surrounding vessel wall, or as a focal region with carotid IMT greater than 1.5 mm that protrudes into the lumen and is distinct from the adjacent boundary. Other signs include shadowing in the wall texture, roughness, and inconsistency in the visualization of structural boundaries together with bright echogenicity.\u003c\/p\u003e\n\u003cp\u003ePrevious studies have taken different approaches to analyzing plaques. Some simply record the \u003cstrong\u003epresence or absence\u003c\/strong\u003e of plaque. Others grade the \u003cstrong\u003esize or burden\u003c\/strong\u003e (mild, moderate, or severe), count the \u003cstrong\u003enumber of visible plaques\u003c\/strong\u003e (none, single, or multiple), or assess the \u003cstrong\u003ecomposition and tissue characteristics\u003c\/strong\u003e (echolucent or calcified).\u003c\/p\u003e\n\u003cp\u003eOne key limitation: reliable characterization of plaque tissue content and features suggestive of plaque instability (like ulceration or a thin fibrous cap) using standard carotid ultrasound is not yet possible. This has led researchers to explore other imaging methods:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePET\/CT scanning:\u003c\/strong\u003e Using positron emission tomography-computerized tomography, researchers found that echolucent plaque (plaque that appears dark on ultrasound) has greater F-18 FDG uptake than calcified plaque or no plaque. This increased uptake seems to imply a high inflammatory state—inflammation being a key driver of plaque rupture.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSpiral CT imaging:\u003c\/strong\u003e Calcified regions of carotid plaque appear as white radiodense areas, contrasting with the remaining non-calcified regions of the plaque and lumen.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHigh-resolution MRI:\u003c\/strong\u003e This imaging technique revealed that \u003cstrong\u003e71% of carotid plaques contain a lipid core\u003c\/strong\u003e—a finding that might provide evidence supporting more aggressive cholesterol-lowering therapy in affected patients.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eComputer-assisted pixel distribution analysis:\u003c\/strong\u003e This new technique can analyze the ultrasound characteristics of complex plaques and accurately quantify intraplaque hemorrhage, fibromuscular tissue, calcium, and lipid content.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe emergence of \u003cstrong\u003e3-dimensional (3D) ultrasound\u003c\/strong\u003e represents another major advance. With 3D ultrasound, plaque areas from all cross-sectional images in the entire image sequence are summed to calculate the \u003cstrong\u003eplaque burden\u003c\/strong\u003e—a measure of total plaque volume. This allows more accurate quantification of plaque volume or area than traditional 2D imaging.\u003c\/p\u003e\n\u003cp\u003eThe authors stress that not only the presence or absence of plaque, but also the \u003cstrong\u003echaracteristics of plaque and plaque burden\u003c\/strong\u003e, can be evaluated with regard to prognosis of cardiovascular events and implications for risk. Echolucent (soft, dark) plaques tend to be lipid-rich, which may indicate higher risk and the need for more aggressive therapy. Echogenic (bright) plaques have a higher content of dense fibrous tissue and calcification.\u003c\/p\u003e\n\n\u003ch2 id=\"biomarkers\"\u003eCombining Ultrasound with Other Heart Risk Biomarkers\u003c\/h2\u003e\n\u003cp\u003eBiomarkers are measurable indicators of biological conditions—they help doctors detect high-risk individuals, diagnose disease promptly and accurately, and evaluate prognosis and treatment outcomes. The review examines how carotid IMT compares with other established biomarkers:\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCoronary artery calcium score (CACS):\u003c\/strong\u003e This CT-based test measures calcium deposits in the coronary arteries. According to the 2013 ACC\/AHA guideline, if a risk-based treatment decision is vague after quantitative traditional risk factor assessment, evaluation of one or more additional factors (family history, hs-CRP, CACS, or ABI) may be considered. The authors note that CACS, which is similar to a structural biomarker of the artery, is useful for diagnosis and as a surrogate marker of ASCVD compared with CCA-IMT or plaque. Carotid plaque and increased carotid IMT are associated with the presence and degree of coronary calcification and disease.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eAnkle-brachial index (ABI):\u003c\/strong\u003e This is a functional biomarker that compares blood pressure in the ankles vs. the arms. In one retrospective study, patients with greater mean CCA-IMT (≥0.9 mm) or lower ABI (\u0026lt;0.9) had significantly higher complexity and presence of coronary artery disease (CAD). The combination of CCA-IMT and ABI together provided additive information for predicting the severity and presence of CAD.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eHigh-sensitivity C-reactive protein (hs-CRP):\u003c\/strong\u003e This is a serological biomarker of inflammation. Another study found that hs-CRP levels and carotid plaque characteristics correlated closely with the severity of CAD. This suggests that combining a blood test for inflammation with an ultrasound look at plaque can give a more complete picture of a patient's risk.\u003c\/p\u003e\n\n\u003ch2 id=\"bloodflow\"\u003eMeasuring Blood Flow in the Carotid Artery\u003c\/h2\u003e\n\u003cp\u003eBeyond measuring artery wall thickness, carotid ultrasound can measure \u003cstrong\u003ehemodynamic parameters\u003c\/strong\u003e—how blood actually flows through the artery. The key measurements include:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePeak-systolic velocity (PSV):\u003c\/strong\u003e The maximum blood flow speed during a heartbeat\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eEnd-diastolic velocity (EDV):\u003c\/strong\u003e The blood flow speed at the end of the heartbeat\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eResistive index (RI):\u003c\/strong\u003e Calculated as (PSV − EDV) \/ PSV, this reflects the resistance to blood flow in the artery\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe evidence for using these measurements is growing:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eIn a case-control study, stroke patients in both the acute (immediate) and chronic stable phase appeared to have lower common carotid blood flow (CBF) velocity and higher resistive index than non-stroke patients—and this was \u003cstrong\u003eindependent of carotid atherosclerosis\u003c\/strong\u003e.\u003c\/li\u003e\n  \u003cli\u003eIn a Taiwanese population at low risk for atherosclerosis, CCA-IMT and EDV could jointly predict the risk of future ischemic stroke events. Notably, the \u003cstrong\u003eEDV value was more strongly associated with ischemic stroke than was CCA-IMT\u003c\/strong\u003e.\u003c\/li\u003e\n  \u003cli\u003eIn a prospective study, carotid flow velocity (CFV) was significantly associated with the development of cardiovascular disease during a median follow-up time of \u003cstrong\u003e12.8 years\u003c\/strong\u003e. CBF velocity, particularly EDV, also \u003cstrong\u003eimproved the risk prediction\u003c\/strong\u003e of cardiovascular disease.\u003c\/li\u003e\n  \u003cli\u003eIn a study of \u003cstrong\u003e1,119 Korean patients\u003c\/strong\u003e without coronary heart disease or stroke, higher RI and lower CCA-PSV and CCA-EDV (but not ICA Doppler indices) were related to future cardiovascular events.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe authors conclude that carotid flow velocity represents a subclinical atherosclerosis index and should be included in the assessment of cardiovascular disease risk.\u003c\/p\u003e\n\n\u003ch2 id=\"implications\"\u003eWhat This Means for Patients\u003c\/h2\u003e\n\u003cp\u003eFor patients, the practical questions are: Should I ask my doctor for a carotid ultrasound? And if I get one, what do the results mean?\u003c\/p\u003e\n\u003cp\u003eBased on this review, here's what patients should understand:\u003c\/p\u003e\n\u003col\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMeasuring IMT alone is no longer recommended as a routine screening test.\u003c\/strong\u003e The 2013 ACC\/AHA guidelines specifically advised against using carotid IMT as a routine measurement for first-event risk assessment. The evidence supports this: CCA-IMT alone adds little to traditional risk factor-based prediction (like the Framingham Risk Score) for 10-year heart attack or stroke risk.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLooking for plaque is more valuable than measuring wall thickness.\u003c\/strong\u003e Carotid plaque appears to be a more powerful predictor of cardiovascular risk than IMT alone. If your doctor orders a carotid ultrasound, the presence, size, number, and characteristics of any plaque are likely to be more informative than the IMT number.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIf IMT is measured, the location matters.\u003c\/strong\u003e Measurements at the carotid bulb and internal carotid artery are more useful for risk classification and prediction than CCA-IMT alone—but these segments are harder to image reliably. The CCA-IMT is the easiest to measure and the most reproducible.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePlaque characteristics provide important clues.\u003c\/strong\u003e If imaging reveals echolucent (soft) plaque, it may be lipid-rich and indicate a higher inflammatory state, which could warrant more aggressive cholesterol-lowering therapy. Calcified (bright) plaque, particularly in elderly hypertensive patients over 60, was shown to predict mortality and cardiovascular outcomes above other risk factors.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBlood flow measurements add value.\u003c\/strong\u003e Carotid flow velocity, especially EDV, has been independently associated with future cardiovascular events and can improve risk prediction. These measurements may become more common in clinical practice as research continues to define their role.\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003ch2 id=\"limitations\"\u003eLimitations: What This Review Could Not Prove\u003c\/h2\u003e\n\u003cp\u003eIt's important to understand the limitations of both the original studies and this review:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMethodological inconsistencies:\u003c\/strong\u003e The \"lack of a uniform methodology in carotid IMT studies\" is a central problem. Different studies used different segments, measurement techniques, statistical models, and cutoff points, limiting the ability to compare results or pool data reliably.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTechnical resolution limits:\u003c\/strong\u003e Standard 7 MHz ultrasound transducers cannot reliably separate the intima and media layers when the IMT complex is thinner than 0.3 mm. The mean intima thickness (~0.2 mm) is right at the edge of what high-frequency transducers can measure. The annual change in IMT (0.01–0.04 mm\/year) is smaller than ultrasound resolution, making short-term monitoring impossible.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eYounger and lower-risk populations:\u003c\/strong\u003e Several studies showed no significant predictive value for carotid IMT in younger patients. This suggests the test may be less useful in younger or lower-risk individuals.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHemodynamic parameters need more research:\u003c\/strong\u003e While promising, the role of carotid flow velocity measurements (PSV, EDV, RI) requires validation in large multicenter studies to establish reproducibility and abnormal cutoff values.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNo standard cutoffs:\u003c\/strong\u003e Abnormal cutoff values for CCA-IMT, plaque presence, and plaque size or volume—adjusted for age, race, and sex—remain to be defined.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"recommendations\"\u003eRecommendations and Future Directions\u003c\/h2\u003e\n\u003cp\u003eThe authors offer several forward-looking recommendations for both clinical practice and future research:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFor clinicians:\u003c\/strong\u003e Combined CCA-IMT and plaque assessment, including plaque tissue characterization and plaque burden using 3D ultrasound, appears to be better than either measurement alone for the assessment and prediction of ASCVD risk.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFor researchers:\u003c\/strong\u003e Future developments in ultrasound technology should focus on separate measurements of the intima and media layers, which could evaluate the effects of different atherosclerotic risk factors (such as metabolic syndrome) on the arterial wall. The authors believe separate measurement will play an important role in evaluating subclinical atherosclerosis and arterial wall remodeling.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFor guideline developers:\u003c\/strong\u003e Future guidelines should consider the roles of plaque presence, plaque burden, and hemodynamic parameters in additional risk stratification beyond carotid IMT.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFor treatment monitoring:\u003c\/strong\u003e Plaque progression and regression assessed by 3D ultrasound may be a powerful method to assess the effect of therapy. Further study is needed to determine changes or remodeling of CCA-IMT and plaque after therapy or intervention.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor patients considering carotid ultrasound, the most practical takeaway is this: \u003cstrong\u003edon't focus on the IMT number alone.\u003c\/strong\u003e Ask your doctor about plaque presence, plaque burden, and blood flow measurements. These provide a more complete picture of your actual cardiovascular risk. And remember—carotid ultrasound is just one piece of the puzzle. It works best when combined with traditional risk factors, blood tests like hs-CRP, and other measurements like ABI and coronary artery calcium scoring.\u003c\/p\u003e\n\u003cp\u003eCarotid ultrasound remains a very useful, simple, and safe method to indirectly detect and prevent cardiovascular disease. But its full potential will only be realized as technology improves—allowing better measurement of plaque characteristics and separate intima\/media layers—and as larger studies help define clear standards for how to use these measurements in everyday practice.\u003c\/p\u003e\n\n\u003c!-- ddn:faq:start --\u003e\n\u003ch2 id=\"ddn-faq\"\u003eFrequently Asked Questions\u003c\/h2\u003e\n\u003ch3\u003eWhat is a carotid artery ultrasound and what does it measure?\u003c\/h3\u003e\n\u003cp\u003eA carotid artery ultrasound is a safe, painless imaging test that uses sound waves to look at the carotid arteries in your neck. It measures artery wall thickness, called intima-media thickness (IMT), checks for plaque, and can measure blood flow velocity. It helps detect early atherosclerosis, the hardening and narrowing of arteries that can lead to heart attack or stroke.\u003c\/p\u003e\n\u003ch3\u003eIs carotid IMT measurement still recommended for heart risk screening?\u003c\/h3\u003e\n\u003cp\u003eThe 2013 ACC\/AHA guidelines no longer recommend measuring carotid IMT alone as a routine test for first heart attack or stroke risk. Adding common carotid IMT to traditional risk scores like the Framingham Risk Score only slightly improves prediction, which researchers say is unlikely to be clinically important. However, combining IMT with plaque detection may still be valuable.\u003c\/p\u003e\n\u003ch3\u003eWhat is carotid plaque and why is it important?\u003c\/h3\u003e\n\u003cp\u003eCarotid plaque is a focal thickening or bright projection on the artery wall, often defined as IMT greater than 1.5 mm. It appears to be a more powerful predictor of cardiovascular risk than IMT alone. Plaque characteristics, such as being echolucent (soft and lipid-rich) or calcified, and plaque burden measured by 3D ultrasound, provide additional risk information.\u003c\/p\u003e\n\u003ch3\u003eCan carotid ultrasound measure blood flow and does it help predict risk?\u003c\/h3\u003e\n\u003cp\u003eYes, carotid ultrasound can measure blood flow velocity, including peak-systolic velocity, end-diastolic velocity, and resistive index. Studies show that lower blood flow velocity, especially end-diastolic velocity, is associated with future cardiovascular events and can improve risk prediction. However, more research is needed before these measurements are widely used in routine clinical practice.\u003c\/p\u003e\n\u003ch3\u003eHow does carotid ultrasound compare to other heart risk tests like coronary calcium score?\u003c\/h3\u003e\n\u003cp\u003eCoronary artery calcium score (CACS), a CT-based test, is similar to a structural biomarker and is useful for diagnosis and as a surrogate marker of cardiovascular disease compared with CCA-IMT or plaque. Carotid plaque and increased IMT are associated with coronary calcification. Combining carotid ultrasound with other biomarkers like hs-CRP or ankle-brachial index gives a more complete risk picture.\u003c\/p\u003e\n\u003ch3\u003eCan carotid ultrasound be used to monitor treatment effects?\u003c\/h3\u003e\n\u003cp\u003eCurrently, measuring IMT changes over short periods is difficult because the annual change is about 0.01 to 0.04 mm per year, which is smaller than the resolution of standard ultrasound. However, plaque progression or regression assessed by 3D ultrasound may be a powerful way to assess therapy effects, but this requires further study before routine use.\u003c\/p\u003e\n\u003c!-- ddn:faq:end --\u003e\n\n\u003ch2 id=\"source\"\u003eSource Information\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eOriginal article title:\u003c\/strong\u003e Korea Is Carotid Artery Ultrasound Still Useful Method for Evaluation of Atherosclerosis?\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eJournal:\u003c\/strong\u003e Korean Circulation Journal, 2017;47(1):1-8\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOI:\u003c\/strong\u003e https:\/\/doi.org\/10.4070\/kcj.2016.0232\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eReceived:\u003c\/strong\u003e June 13, 2016 | \u003cstrong\u003eAccepted:\u003c\/strong\u003e June 30, 2016\u003c\/p\u003e\n\u003cp\u003eThis patient-friendly article is based on peer-reviewed research published as an open-access review article. The authors declared no financial conflicts of interest.\u003c\/p\u003e","brand":"DiagnosticDetectives.Com","offers":[{"title":"Default Title","offer_id":47427816915100,"sku":null,"price":0.0,"currency_code":"JPY","in_stock":true}],"url":"https:\/\/diagnosticdetectives.jp\/products\/carotid-artery-ultrasound-and-heart-risk-is-this-simple-painless-test-still-worthwhile","provider":"DiagnosticDetectives.Com","version":"1.0","type":"link"}